“Orange Book” Certifications Would List Patent Claims Under Rockefeller Bill
Executive Summary
"Orange Book" patent certifications would include an enumeration of the relevant claims under generic drug reform legislation introduced by Sen. Jay Rockefeller (D-W.Va.)
You may also be interested in...
FDA Patent Listing Criteria Allow Polymorph, Product-By-Process Claims
FDA's proposed reforms to the Orange Book patent listing procedures would allow companies to list patents covering polymorphs and some types of manufacturing processes
FDA, USP Should Set Generic Biologics Standards, Sen. Hatch Proposes
Generic biologics should be a priority issue for the next FDA commissioner, Sen. Orrin Hatch (R-Utah) says
FDA, USP Should Set Generic Biologics Standards, Sen. Hatch Proposes
Generic biologics should be a priority issue for the next FDA commissioner, Sen. Orrin Hatch (R-Utah) says